Laird Norton Wetherby Wealth Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$235K Sell
8,919
-215
-2% -$5.53K 0.01% 831
2025
Q2
$261K Buy
+9,134
New +$245K 0.01% 782
2024
Q4
$225K Buy
9,932
+65
+0.7% +$1.41K 0.01% 799
2024
Q3
$210K Sell
9,867
-351
-3% -$6.91K 0.01% 852
2024
Q2
$195K Buy
10,218
+36
+0.4% +$734 0.01% 857
2024
Q1
$196K Sell
10,182
-440
-4% -$8.72K 0.01% 889
2023
Q4
$221K Sell
10,622
-4,370
-29% -$83.9K 0.01% 827
2023
Q3
$323K Sell
14,992
-418
-3% -$10.1K 0.02% 670
2023
Q2
$369K Buy
15,410
+904
+6% +$20.7K 0.02% 645
2023
Q1
$308K Buy
14,506
+3,733
+35% +$71.5K 0.02% 695
2022
Q4
$176K Sell
10,773
-3,660
-25% -$54.3K 0.01% 820
2022
Q3
$203K Buy
+14,433
New +$273K 0.01% 795
2022
Q2
Sell
-6,807
Closed -$229K 941
2022
Q1
$229K Buy
6,807
+560
+9% +$18.4K 0.01% 811
2021
Q4
$203K Sell
6,247
-2,308
-27% -$76K 0.01% 863
2021
Q3
$299K Sell
8,555
-18
-0.2% -$703 0.02% 710
2021
Q2
$356K Buy
8,573
+1,287
+18% +$51.4K 0.02% 651
2021
Q1
$269K Sell
7,286
-668
-8% -$25.3K 0.02% 645
2020
Q4
$331K Sell
7,954
-304
-4% -$12.7K 0.02% 624
2020
Q3
$350K Buy
8,258
+2
+0% +$86 0.03% 478
2020
Q2
$358K Buy
8,256
+212
+3% +$8.38K 0.03% 449
2020
Q1
$264K Buy
8,044
+1,859
+30% +$69.1K 0.03% 486
2019
Q4
$227K Sell
6,185
-1,076
-15% -$38.2K 0.02% 628
2019
Q3
$244K Sell
7,261
-2,971
-29% -$105K 0.03% 608
2019
Q2
$402K Buy
10,232
+1,285
+14% +$50.9K 0.04% 451
2019
Q1
$362K Sell
8,947
-3,014
-25% -$112K 0.05% 454
2018
Q4
$387K Sell
11,961
-2,986
-20% -$121K 0.05% 396
2018
Q3
$769K Sell
14,947
-42
-0.3% -$2.1K 0.1% 242
2018
Q2
$755K Buy
14,989
+98
+0.7% +$4.97K 0.1% 236
2018
Q1
$761K Buy
14,891
+194
+1% +$10.3K 0.11% 228
2017
Q4
$772K Sell
14,697
-469
-3% -$23.3K 0.11% 227
2017
Q3
$741K Buy
15,166
+208
+1% +$9.89K 0.11% 220
2017
Q2
$723K Sell
14,958
-70
-0.5% -$3.22K 0.12% 210
2017
Q1
$633K Sell
15,028
-353
-2% -$14.6K 0.11% 231
2016
Q4
$650K Buy
15,381
+1,236
+9% +$50.4K 0.13% 204
2016
Q3
$619K Buy
14,145
+3,487
+33% +$156K 0.13% 201
2016
Q2
$464K Sell
10,658
-536
-5% -$23.1K 0.1% 238
2016
Q1
$493K Sell
11,194
-86
-0.8% -$3.64K 0.12% 214
2015
Q4
$472K Buy
11,280
+218
+2% +$9.19K 0.11% 213
2015
Q3
$432K Buy
11,062
+372
+3% +$15.1K 0.11% 226
2015
Q2
$445K Buy
10,690
+662
+7% +$28.3K 0.11% 235
2015
Q1
$416K Sell
10,028
-50
-0.5% -$1.93K 0.1% 247
2014
Q4
$375K Sell
10,078
-856
-8% -$30.8K 0.09% 257
2014
Q3
$379K Buy
10,934
+2,134
+24% +$73.6K 0.11% 242
2014
Q2
$295K Sell
8,800
-1,404
-14% -$46.8K 0.08% 301
2014
Q1
$356K Buy
10,204
+338
+3% +$11.8K 0.1% 257
2013
Q4
$351K Buy
9,866
+316
+3% +$10.6K 0.1% 246
2013
Q3
$309K Sell
9,550
-76
-0.8% -$2.48K 0.1% 258
2013
Q2
$339K Buy
+9,626
New +$335K 0.12% 203

Other funds holding FMS

Laird Norton Wetherby Wealth Management's FMS Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management reduced its Fresenius Medical Care (FMS) stake by 2.4% in Q3 2025, selling an estimated $5.53K and leaving 8,919 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #831.

Laird Norton Wetherby Wealth Management first reported a position in FMS in Q2 2013 and has held it in 48 quarters since. The position peaked at $772K in Q4 2017. 205 funds tracked by Wall St. Rank hold FMS as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 8,919 shares of Fresenius Medical Care worth $235K as of Q3 2025.
  • Laird Norton Wetherby Wealth Management sold 215 Fresenius Medical Care shares in Q3 2025, an estimated $5.53K.
  • Fresenius Medical Care made up 0.01% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #831 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Fresenius Medical Care in Q2 2013 and has held it in 48 quarters since.
  • Laird Norton Wetherby Wealth Management's Fresenius Medical Care position peaked at $772K in Q4 2017.
  • 205 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.